patent/PH-12014501434-B1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12014501434-B1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate	2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91a268b02c628013fb1e8f249ce4cbfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_568a0d10f46c4e79031d197dc5aab026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d61336dfee9336f059e101f4c56e8076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a143a543b6376981a2694809d27eb882 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2eb35e648947b5ecef84a3a408219db
publicationDate	2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PH-12014501434-B1
titleOfInvention	Quinoline derivatives as pde10a enzyme inhibitors
abstract	The present invention provides quinoline derivatives of formula (I) that are PDE10A enzyme inhibitors, and as such are useful to treat neurodegenerative and psychiatric disorders. Especially, the invention provides compounds that are highly selective for PDE10 over other PDE subtypes. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.
priorityDate	2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10846 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23984 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID63885

Total number of triples: 36.